Furthermore, we also found that the positive expression proportion of CD34, CD117, and CD123 was significantly higher in the CD7+ AML group than in the CD7- AML group, and the proportion of positive expression of CD4- was lower than in the CD7- AML group. This evidence concerns the gene KIT and acute myeloid leukemia.